SiRNA and innate immunity

Oligonucleotides

Volumn 19, Issue 2, 2009, Pages 89-101

  Robbins, Marjorie ^a   Judge, Adam ^a   MacLachlan, Ian ^a  

^a Tekmira Pharmaceuticals Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTISENSE OLIGONUCLEOTIDE; BETA INTERFERON; CYTOKINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 6; LIPID; LIPOPOLYSACCHARIDE; LIPOSOME; METHYLCELLULOSE; POLYINOSINIC POLYCYTIDYLIC ACID; POLYLYSINE; RETINOIC ACID INDUCIBLE PROTEIN I; RIBOZYME; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; STABLE NUCLEIC ACID LIPID PARTICLE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CANCER GENE THERAPY; CHEMICAL MODIFICATION; CHILL; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SAFETY; FEVER; FLU LIKE SYNDROME; HUMAN; HYPOTENSION; IMMUNOSTIMULATION; IMMUNOTOXICITY; INFLUENZA; INNATE IMMUNITY; LIPOSOMAL GENE DELIVERY SYSTEM; MELANOMA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RIGOR; RNA DEGRADATION; RNA INTERFERENCE; RNA SEQUENCE; RNA STABILITY; RNA STRUCTURE;

ANIMALS; ANTIGEN-PRESENTING CELLS; CYTOKINES; DEAD-BOX RNA HELICASES; HUMANS; IMMUNITY, INNATE; INTERFERONS; LYMPHOCYTE ACTIVATION; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 8;

MAMMALIA;

EID: 66249105368     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0180     Document Type: Review

References (99)

1. AKIRA, S., and TAKEDA, K. (2004). Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
2. ALEXOPOULOU, L., CZOPIK-HOLT, A., MEDZHITOV, R., and FLAVELL, R. (2001). Recognition of double-stranded RNA and activation of NF-KB by toll-like receptor 3. Nature. 413, 732-738.
3. ALLERSON, C.R., SIOUFI, N., JARRES, R., PRAKASH, T.P., NAIK, N., BERDEJA, A., WANDERS, L., GRIFFEY, R.H., SWAYZE, E.E., and BHAT, B. (2005). Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J. Med. Chem. 48, 901-904.
4. APPLEQUIST, S.E., WALLIN, R.P., and LJUNGGREN, H.G. (2002). Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int. Immunol. 14, 1065-1074.
5. ASSELIN-PATUREL, C., and TRINCHIERI, G. (2005). Production of type I interferons: plasmacytoid dendritic cells and beyond. J. Exp. Med. 202, 461-465.
6. BALACHANDRAN, S., VENKATARAMAN, T., FISHER, P.B., and BARBER, G.N. (2007). Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J. Immunol. 178, 2429-2439.
7. BITKO, V., MUSIYENKO, A., SHULYAYEVA, O., and BARIK, S. (2005). Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11, 50-55.
8. BRANNON-PEPPAS, L., GHOSN, B., ROY, K., and CORNETTA, K. (2007). Encapsulation of nucleic acids and opportunities for cancer treatment. Pharm. Res. 24, 618-627.
9. BRIDGE, A.J., PEBERNARD, S., DUCRAUX, A., NICOULAZ, A.-L., and IGGO, R. (2003). Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264.
10. CEKAITE, L., FURSET, G., HOVIG, E., and SIOUD, M. (2007). Gene Expression Analysis in Blood Cells in Response to Unmodified and 2′-Modified siRNAs Reveals TLR-dependent and Independent Effects. J. Mol. Biol. 365, 90-108.
11. CHIU, Y., and RANA, T. (2003). siRNA function in RNAi: A chemical modification analysis. RNA. 9, 1034-1048.
12. CLEMENS, M.J., and ELIA, A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17, 503-524.
13. COLLINGWOOD, M.A., ROSE, S.D., HUANG, L., HILLIER, C., AMARZGUIOUI, M., WIIGER, M.T., SOIFER, H.S., ROSSI, J.J., and BEHLKE, M.A. (2008). Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs. Oligonucleotides. 18, 187-200.
14. CZAUDERNA, F., FECHTNER, M., DAMES, S., AYGÜN, H., KLIPPEL, A., PRONK, G.J., GIESE, K., and KAUFMANN, J. (2003). Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 31, 2705-2716.
15. DER, S.D., ZHOU, A., WILLIAMS, B.R., and SILVERMAN, R.H. (1998). Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA. 95, 15623-15628.
16. DIEBOLD, S.S., KAISHO, T., HEMMI, H., AKIRA, S., and REISE SOUSA, C. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303, 1529-1531.
17. DIEBOLD, S.S., MASSACRIER, C., AKIRA, S., PATUREL, C., MOREL, Y., and REIS e SOUSA, C. (2006). Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur. J. Immunol. 36, 3256-3267.
18. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411, 494-498.
19. ELMEN, J., THONBERG, H., LJUNGBERG, K., FRIEDEN, M., WESTERGAARD, M., XU, Y., WAHREN, B., LIANG, Z., ØRUM, H., KOCH, T., and WAHLESTEDT, C. (2005). Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33, 439-447.
20. FOLKMAN, J., and INGBER, D. (1992). Inhibition of angiogenesis. Semin. Cancer Biol. 3, 89-96.
21. FORSBACH, A., NEMORIN, J.G., MONTINO, C., MÜLLER, C., SAMULOWITZ, U., VICARI, A.P., JURK, M., MUTWIRI, G.K., KRIEG, A.M., LIPFORD, G.B., and VOLLMER, J. (2008). Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. J. Immunol. 180, 3729-3738.
22. FOSS, F.M. (2002). Immunologic mechanisms of antitumor activity. Semin. Oncol. 29, 5-11.
23. GANTIER, M.P., TONG, S., BEHLKE, M.A., XU, D., PHIPPS, S., FOSTER, P.S., and WILLIAMS, B.R. (2008). TLR7 is involved in sequence-specific sensing of single-stranded RNAs in human macrophages. J. Immunol. 180, 2117-2124.
24. GE, Q., FILIP, L., BAI, A., NGUYEN, T., EISEN, H.N., and CHEN, J. (2004). Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA. 101, 8676-8681.
25. GEISBERT, T.W., HENSLEY, L.E., KAGAN, E., YU, E.Z., GEISBERT, J.B., DADDARIO-DICAPRIO, K., FRITZ, E.A., JAHRLING, P.B., MCCLINTOCK, K., PHELPS, J.R., LEE, A.C., JUDGE, A., JEFFS, L.B., and MACLACHLAN, I. (2006). Postexposure protection of guinea pigs against a lethal ebola virus challenge by RNA interference. J. Infect. Dis. 193, 1650-1657.
26. GEISS, G., JIN, G., GUO, J., BUMGARNER, R., KATZE, M.G., and SEN, G.C. (2001). A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 276, 30178-30182.
27. GITLIN, L., KARELSKY, S., and ANDINO, R. (2002). Short interfering RNA confers intracellular antiviral immunity in human cells. Nature. 418, 430-434.
28. GORDEN, K.B., GORSKI, K.S., GIBSON, S.J., KEDL, R.M., KIEPER, W.C., QIU, X., TOMAI, M.A., ALKAN, S.S., and VASILAKOS, J.P. (2005). Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J. Immunol. 174, 1259-1268.
29. GORDEN, K.K., QIU, X.X., BINSFELD, C.C., VASILAKOS, J.P., and ALKAN, S.S. (2006). Cutting Edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and PolyT oligodeoxynucleotides. J. Immunol. 177, 6584-6587.
30. HEIDEL, J.D., HU, S., LIU, X.F., TRICHE, T.J., and DAVIS, M.E. (2004). Lack of interferon response in animals to naked siRNAs. Nat. Biotechnol. 22, 1579-1582.
31. HEIL, F., HEMMI, H., HOCHREIN, H., AMPENBERGER, F., KIRSCHNING, C., AKIRA, S., LIPFORD, G., WAGNER, H., and BAUER, S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303, 1526-1529.
32. HISCOTT, J., LIN, R., NAKHAEI, P., and PAZ, S. (2006). MasterC ARD: a priceless link to innate immunity. Trends Mol. Med. 12, 53-56.
33. HONDA, K., OHBA, Y., YANAI, H., NEGISHI, H., MIZUTANI, T., TAKAOKA, A., TAYA, C., and TANIGUCHI, T. (2005). Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 434, 1035-1040.
34. HORNUNG, V., ELLEGAST, J., KIM, S., BRZÓZKA, K., JUNG, A., KATO, H., POECK, H., AKIRA, S., CONZELMANN, K.K., SCHLEE, M., ENDRES, S., and HARTMANN, G. (2006). 5′-Triphosphate RNA is the ligand for RIG-I. Science. 314, 994-997.
35. HORNUNG, V., GUENTHNER-BILLER, M., BOURQUIN, C., ABLASSER, A., SCHLEE, M., UEMATSU, S., NORONHA, A., MANOHARAN, M., AKIRA, S., de FOUGEROLLES, A., ENDRES, S., and HARTMANN, G. (2005). Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med. 11, 263-270.
36. HORNUNG, V., ROTHENFUSSER, S., BRITSCH, S., KRUG, A., JAHRSDÖRFER, B., GIESE, T., ENDRES, S., and HARTMANN, G. (2002). Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
37. ITO, T., AMAKAWA, R., INABA, M., IKEHARA, S., INABA, K., and FUKUHARA, S. (2001). Differential regulation of human blood dendritic cell subsets by IFNs. J. Immunol. 166, 2961-2969.
38. JUDGE, A.D., BOLA, G., LEE, A.C., and MACLACHLAN, I. (2006). Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther. 13, 494-505.
39. JUDGE, A., and MACLACHLAN, I. (2008). Overcoming the innate immune response to small interfering RNA. Hum. Gene Ther. 19, 111-124.
40. JUDGE, A.D., SOOD, V., SHAW, J.R., FANG, D., MCCLINTOCK, K., and MACLACHLAN, I. (2005). Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23, 457-462.
41. JUDGE, A.D., ROBBINS, M., TAVAKOLI, I., LEVI, J., HU, L., FRONDA, A., AMBEGIA, E., MCCLINTOCK, K., MACLACHLAN, I. (2009). Confirming the RNAi-mediated mechanism of action of siRNA-based therapeutics in mice. J. Clin. Invest. 119, 661-73.
42. KADOWAKI, N., HO, S., ANTONENKO, S., MALEFYT, R.W., KASTELEIN, R.A., BAZAN, F., and LIU, Y.J. (2001). Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194, 863-869.
43. KARIKÓ, K., BHUYAN, P., CAPODICI, J., and WEISSMAN, D. (2004). Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through Toll-like receptor-3. J. Immunol. 172, 6545-6549.
44. KARIKÓ, K., BUCKSTEIN, M., NI, H., and WEISSMAN, D. (2005). Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 23, 165-175.
45. KATO, H., SATO, S., YONEYAMA, M., YAMAMOTO, M., UEMATSU, S., MATSUI, K., TSUJIMURA, T., TAKEDA, K., FUJITA, T., TAKEUCHI, O., and AKIRA, S. (2005). Cell type-specific involvement of RIG-I in antiviral response. Immunity. 23, 19-28.
46. KATO, H., TAKEUCHI, O., SATO, S., YONEYAMA, M., YAMAMOTO, M., MATSUI, K., UEMATSU, S., JUNG, A., KAWAI, T., ISHII, K.J., YAMAGUCHI, O., OTSU, K., TSUJIMURA, T., KOH, C.S., REIS E SOUSA, C., MATSUURA, Y., FUJITA, T., and AKIRA, S. (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441, 101-105.
47. KAWAI, T., and AKIRA, S. (2006). Innate immune recognition of viral infection. Nat. Immunol. 7, 131-137.
48. KAWAI, T., TAKAHASHI, K., SATO, S., COBAN, C., KUMAR, H., KATO, H., ISHII, K.J., TAKEUCHI, O., and AKIRA, S. (2005). IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988.
49. KIM, D.H., BEHLKE, M.A., ROSE, S.D., CHANG, M.S., CHOI, S., and ROSSI, J.J. (2005). Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222-226.
50. KIM, D-H, LONGO, M., HAN, Y., LUNDBERG, P., CANTIN, E., and ROSSI, J.J. (2004). Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase. Nat. Biotechnol. 22, 321-325.
51. KLEINMAN, M.E., YAMADA, K., TAKEDA, A., CHANDRASEKARAN, V., NOZAKI, M., BAFFI, J.Z., ALBUQUERQUE, R.J., YAMASAKI, S., ITAYA, M., PAN, Y., APPUKUTTAN, B., GIBBS, D., YANG, Z., KARIKÓ, K., AMBATI, B.K., WILGUS, T.A., DIPIETRO, L.A., SAKURAI, E., ZHANG, K., SMITH, J.R., TAYLOR, E.W., and AMBATI, J. (2008). Sequence-and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 452, 591-597.
52. KRIEG, A.M. (2006). Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. 5, 471-484.
53. LAYZER, J., MCCAFFREY, A., TANNER, A., HUANG, Z., KAY, M., and SULLENGER, B. (2004). In vivo activity of nuclease resistant siRNAs. RNA. 10, 766-771.
54. LEE, J., CHUANG, T.H., REDECKE, V., SHE, L., PITHA, P.M., CARSON, D.A., RAZ, E., and COTTAM, H.B. (2003). Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA. 100, 6646-6651.
55. LEUSCHNER, P.J., AMERES, S.L., KUENG, S., and MARTINEZ, J. (2006). Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep. 7, 314-320.
56. LI, B.J., TANG, Q., CHENG, D., QIN, C., XIE, F.Y., WEI, Q., XU, J., LIU, Y., ZHENG, B.J., WOODLE, M.C., ZHONG, N., and LU, P.Y. (2005). Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat. Med. 11, 944-951.
57. LUND, J.M., ALEXOPOULOU, L., SATO, A., KAROW, M., ADAMS, N.C., GALE, N.W., IWASAKI, A., and FLAVELL, R.A. (2004). Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA. 101, 5598-5603.
58. LYNN, M., ROSSIGNOL, D.P., WHEELER, J.L., KAO, R.J., PERDOMO, C.A., NOVECK, R., VARGAS, R., D'ANGELO, T., GOTZKOWSKY, S., and MCMAHON, F.G. (2003). Blocking of responses to endo-toxin by E5564 in healthy volunteers with experimental endotox-emia. J. Infect. Dis. 187, 631-639.
59. MANCHE, L., GREEN, S.R., SCHMEDT, C., and MATHEWS, M.B. (1992). Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12, 5238-5248.
60. MANOHARAN, M. (2004). RNA interference and chemically modified small interfering RNAs. Curr. Opin. Chem. Biol. 8, 570-579.
61. MARQUES, J.T., DEVOSSE, T., WANG, D., ZAMANIAN-DARYOUSH, M., SERBINOWSKI, P., HARTMANN, R., FUJITA, T., BEHLKE, M.A., and WILLIAMS, B.R. (2006). A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat. Biotechnol. 24, 559-565.
62. MATRANGA, C., TOMARI, Y., SHIN, C., BARTEL, D.P., and ZAMORE, P.D. (2005). Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell. 123, 607-620.
63. MEURS, E., CHONG, K., GALABRU, J., THOMAS, N.S., KERR, I.M., WILLIAMS, B.R., and HOVANESSIAN, A.G. (1990). Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62, 379-390.
64. MEYLAN, E., CURRAN, J., HOFMANN, K., MORADPOUR, D., BINDER, M., BARTENSCHLAGER, R., and TSCHOPP, J. (2005). Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature. 437, 1167-1172.
65. MICHIE, H.R., MANOGUE, K.R., SPRIGGS, D.R., REVHAUG, A., O'DWYER, S., DINARELLO, C.A., CERAMI, A., WOLFF, S.M., and WILMORE, D.W. (1988). Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318, 1481-1486.
66. MORRISSEY, D.V., BLANCHARD, K., SHAW, L., JENSEN, K., LOCKRIDGE, J.A., DICKINSON, B., MCSWIGGEN, J.A., VARGEESE, C., BOWMAN, K., SHAFFER, C.S., POLISKY, B.A., and ZINNEN, S. (2005). Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus infection. Hepatology. 41,1349-1356.
67. MORRISSEY, D.V., LOCKRIDGE, J.A., SHAW, L., BLANCHARD, K., JENSEN, K., BREEN, W., HARTSOUGH, K., MACHEMER, L., RADKA, S., JADHAV, V., VAISH, N., ZINNEN, S., VARGEESE, C., BOWMAN, K., SHAFFER, C.S., JEFFS, L.B., JUDGE, A., MACLACHLAN, I., and POLISKY, B. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNA's. Nat. Biotechnol. 23, 1002-1007.
68. MUZIO, M., BOSISIO, D., POLENTARUTTI, N., D'AMICO, G., STOPPACCIARO, A., MANCINELLI, R., VAN'T VEER, C., PENTON-ROL, G., RUCO, L.P., ALLAVENA, P., and MANTOVANI, A. (2000). Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164, 5998-6004.
69. PALLISER, D., CHOWDHURY, D., WANG, Q.Y., LEE, S.J., BRONSON, R.T., KNIPE, D.M., and LIEBERMAN, J. (2006). An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature. 439, 89-94.
70. PETERS, K.L., SMITH, H.L., STARK, G.R., and SEN, G.C. (2002). IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. USA. 99, 6322-6327.
71. PICHLMAIR, A., SCHULZ, O., TAN, C.P., NÄSLUND, T.I., LILJESTRÖM, P., WEBER, F., and REIS e SOUSA, C. (2006). RIGI-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science. 314, 997-1001.
72. POECK, H., BESCH, R., MAIHOEFER, C., RENN, M., TORMO, D., MORSKAYA, S.S., KIRSCHNEK, S., GAFFAL, E., LANDSBERG, J., HELLMUTH, J., SCHMIDT, A., ANZ, D., BSCHEIDER, M., SCHWERD, T., BERKING, C., BOURQUIN, C., KALINKE, U., KREMMER, E., KATO, H., AKIRA, S., MEYERS, R., HÄCKER, G., NEUENHAHN, M., BUSCH, D., RULAND, J., ROTHENFUSSER, S., PRINZ, M., HORNUNG, V., ENDRES, S., TÜTING, T., and HARTMANN, G. (2008). 5'-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma. Nat. Med. 14, 1256-1263.
73. PRAKASH, T., ALLERSON, C.R., DANDE, P., VICKERS, T.A., SIOUFI, N., JARRES, R., BAKER, B.F., SWAYZE, E.E., GRIFFEY, R.H., and BHAT, B. (2005). Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 48, 4247-4253.
74. PUTHENVEETIL, S., WHITBY, L., REN, J., KELNAR, K., KREBS, J.F., and BEAL, P.A. (2006). Controlling activation of the RNA-dependent protein kinase by siRNAs using site-specific chemical modification. Nucleic Acids Res. 34, 4900-4911.
75. ROBBINS, M., JUDGE, A., AMBEGIA, E., CHOI, C., YAWORSKI, E., PALMER, L., MCCLINTOCK, K., and MACLACHLAN, I. (2008). Misinterpreting the therapeutic effects of siRNA caused by immune stimulation. Hum. Gene Ther. [Epub Ahead of print].
76. ROBBINS, M., JUDGE, A., LIANG, L., MCCLINTOCK, K., YAWORSKI, E., and MACLACHLAN, I. (2007). 2′-O-methyl-modified RNAs Act as TLR7 Antagonists. Mol. Ther. 15(9), 1663-1669.
77. SANTEL, A., ALEKU, M., KEIL, O., ENDRUSCHAT, J., ESCHE, V., DURIEUX, B., LÖFFLER, K., FECHTNER, M., RÖHL, T., FISCH, G., DAMES, S., ARNOLD, W., GIESE, K., KLIPPEL, A., and KAUFMANN, J. (2006). RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther. 13, 1360-1370.
78. SARAVOLAC, E.G., SABUDA, D., CRIST, C., BLASETTI, K., SCHNELL, G., YANG, H., KENDE, M., LEVY, H.B., and WONG, J.P. (2001). Immunoprophylactic strategies against respiratory invuenza virus infection. Vaccine. 19, 2227-2232.
79. SETH, R.B., SUN, L., EA, C.K., and CHEN, Z.J. (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 122, 669-682.
80. SHARARA, A.I., PERKINS, D.J., MISUKONIS, M.A., CHAN, S.U., DOMINITZ, J.A., and WEINBERG, J.B. (1997). Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J. Exp. Med. 186, 1495-1502.
81. SIOUD, M. (2005). Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNA is sequence dependent and requires endosomal localization. J. Mol. Biol. 348, 1079-1090.
82. SLEDZ, C.A., HOLKO, M., de VEER, M.J., SILVERMAN, R.H., and WILLIAMS, B.R. (2003). Activation of the interferon system by short-interfering RNAs. Nat. Cell. Biol. 5, 834-839.
83. SOUTSCHEK, J., AKINC, A., BRAMLAGE, B., CHARISSE, K., CONSTIEN, R., DONOGHUE, M., ELBASHIR, S., GEICK, A., HADWIGER, P., HARBORTH, J., JOHN, M., KESAVAN, V., LAVINE, G., PANDEY, R.K., RACIE, T., RAJEEV, K.G., RÖHL, I., TOUDJARSKA, I., WANG, G., WUSCHKO, S., BUMCROT, D., KOTELIANSKY, V., LIMMER, S., MANOHARAN, M., and VORNLOCHER, H.P. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 432, 173-178.
84. STEVENSON, H.C., ABRAMS, P.G., SCHOENBERGER, C.S., SMALLEY, R.B., HERBERMAN, R.B., and FOON, K.A. (1985). A phase I evaluation of poly(I,C)-LC in cancer patients. J. Biol. Response Mod. 4, 650-655.
85. TAKEDA, K., and AKIRA, S. (2005). Toll-like receptors in innate immunity. Int. Immunol. 17, 1-14.
86. TAKEDA, K., KAISHO, T., and AKIRA, S. (2003). Toll-like Receptors. Ann. Rev. Immunol. 21, 335-376.
87. TOMPKINS, S.M., LO, C.Y., TUMPEY, T.M., and EPSTEIN, S.L. (2004). Protection against lethal influenza virus challenge by RNA interference in vivo. Proc. Natl. Acad. Sci. USA. 101, 8682-8686.
88. VON MARSCHALL, Z., SCHOLZ, A., CRAMER, T., SCHÄFER, G., SCHIRNER, M., OBERG, K., WIEDENMANN, B., HÖCKER, M., and ROSEWICZ, S. (2003). Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J. Natl Cancer Inst. 95, 437-448.
89. WILLIAMS, B.R. (2001). Signal integration via PKR. Sci. STKE 2001, RE2.
90. WU, W.Z., SUN, H.C., SHEN, Y.F., CHEN, J., WANG, L., TANG, Z.Y., ILIAKIS, G., and LIU, K.D. (2005). Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways. J. Cancer Res. Clin. Oncol. 131, 169-178.
91. XU, L.G., WANG, Y.Y., HAN, K.J., LI, L.Y., ZHAI, Z., and SHU, H.B. (2005). VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell. 19, 727-740.
92. YAMAMOTO, M., SATO, S., HEMMI, H., HOSHINO, K., KAISHO, T., SANJO, H., TAKEUCHI, O., SUGIYAMA, M., OKABE, M., TAKEDA, K., and AKIRA, S. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301, 640-643.
93. YAMAMOTO, M., SATO, S., MORI, K., HOSHINO, K., TAKEUCHI, O., TAKEDA, K., and AKIRA, S. (2002). Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668-6672.
94. YEO, S.J., YOON, J.G., and YI, A.K. (2003). Myeloid differentiation factor 88-dependent post-transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: Tumor necrosis factor-alpha receptor-associated factor 6, a diverging point in the Toll-like receptor 9-signaling. J. Biol. Chem. 278, 40590-40600.
95. YONEYAMA, M., KIKUCHI, M., MATSUMOTO, K., IMAIZUMI, T., MIYAGISHI, M., TAIRA, K., FOY, E., LOO, Y.M., GALE, M., JR., AKIRA, S., YONEHARA, S., KATO, A., and FUJITA, T. (2005). Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851-2858.
96. YONEYAMA, M., KIKUCHI, M., NATSUKAWA, T., SHINOBU, N., IMAIZUMI, T., MIYAGISHI, M., TAIRA, K., AKIRA, S., and FUJITA, T. (2004). The RNA helicase RIG-1 has an essential function in double-stranded RNA induced innate antiviral responses. Nat. Immunol. 5, 730-737.
97. ZAMANIAN-DARYOUSH, M., MARQUES, J.T., GANTIER, M.P., BEHLKE, M.A., JOHN, M., RAYMAN, P., FINKE, J., and WILLIAMS, B.R. (2008). Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells. J. Interferon Cytokine Res. 28, 221-233.
98. ZAREMBER, K.A., and GODOWSKI, P.J. (2002). Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168, 554-561.
99. ZHANG, Z., WEINSCHENK, T., GUO, K., and SCHLUESENER, H.J. (2006). siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. J. Cell. Biochem. 97, 1217-1229.